We analyze noise-free headlines and recent hype associated with BioTime which may create opportunities for some arbitrage if properly timed. With BioTime hype-based prediction module you can estimate the value of BioTime from the prospective of BioTime response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BioTime over a specific investment horizon. Check also Trending Equities.
BioTime is currently traded for 558.20on Tel Aviv Stock Exchange of Israel. The entity has historical hype elasticity of 4.77 and average elasticity to hype of competition of -26.83. BioTime is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 388.57%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at 2.27%. The volatility of relative hype elasticity to BioTime is about 69.04%%. The volatility of related hype on BioTime is about 69.04% with expected price after next announcement by competition of 531.37. About 46.0% of the company shares are held by company insiders. The company recorded loss per share of 0.58. BioTime had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be in a few days. Check also Trending Equities.